logo
episode-header-image
Jun 2024
1h 15m

The Dark Story Behind Ozempic’s $500B Bu...

Hubspot Media
About this episode
Episode 601: Sam Parr ( https://twitter.com/theSamParr ) and Shaan Puri ( https://twitter.com/ShaanVP ) talk to Calley Means ( https://x.com/calleymeans ) about the $50T drug that has Americans in a chokehold.  — Show Notes: (0:00) Intro  (1:54) The problem with Ozempic (4:25) America is a dirty fish tank (9:58) The Flexner Report (12:06) 90% of doctors nev ... Show More
Up next
Jul 7
5 ruthless business lessons from one week in NYC
Sam's guide to run your life like a $100M business: https://clickhubspot.com/krhd Episode 839: Sam Parr ( https://x.com/theSamParr ) and Shaan Puri ( https://x.com/ShaanVP ) talk about everything Shaan learned from his NYC trip. — Show Notes: (0:00) Lesson: Proximity (9:11) Lesso ... Show More
1h 2m
Jul 2
I dropped out of college and built a $3.6B company from scratch
Get Sam and Shaan's hard-won CEO lessons in one guide: https://clickhubspot.com/ktng Episode 838: Sam Parr ( https://x.com/theSamParr ) and Shaan Puri ( https://x.com/ShaanVP ) talk to Aaron Levie ( https://x.com/levie ) talk about building Box, getting rich slowly, why AI might ... Show More
58m 25s
Jun 30
3 weird businesses doing $10M, $20M, $30M
Business Idea Database: https://clickhubspot.com/ecat Episode 837: Sam Parr ( https://x.com/theSamParr ) and Shaan Puri ( https://x.com/ShaanVP ) bring in 3 founders with weird businesses making $10M, $20M, and $30M. — Show Notes: (0:00) Intro (3:32) Alex Daniels, $10M real estat ... Show More
1h 10m
Recommended Episodes
Sep 2023
2. The drug behind Europe's most valuable company
How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discove ... Show More
56m 39s
Oct 2023
Weightloss Drug OZEMPIC: What They're NOT Telling You! With Lee Fang
<p>Russell chats to Lee Fang, an independent journalist on Substack, who worked for Elon on the Twitter Files revelations, about a drugmaker appearing to push for profit over health with a new weightloss drug, Ozempic. with the obesity treatment market  projected to reach $71 bil ... Show More
44m 39s
Nov 2023
33. The Ozempic Trade: "Health" and Body Image on Wall Street Feat. Lindsey Lusson
Send us Fan Mail Ozempic and similar drugs are dominating the conversation about culture, health, and financial markets right now. But what does it mean for Wall Street --- not just for investors, but also in terms of its impact on the social norms of the industry? **TRIGGER WARN ... Show More
1h 3m
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Oct 2023
Ozempic’s Success Is Bad News for Rivals
Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.See omnystudio.com/listener for privacy information ... Show More
7m 10s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Oct 2023
Ozempic
tail spinning
58m 21s
Dec 2024
615. Is Ozempic as Magical as It Sounds?
<p>In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. ... Show More
56m 49s
Apr 2024
Ozempic Expert: Ozempic Increases This Disease By A Factor Of 9! They're Lying To You About Ozempic Side Effects & What It's Doing To Our Brains! - Johann Hari
It is being called a miracle drug, but what is the dark side to the weight loss medication Ozempic? Johann Hari is a New York Times best-selling author, his books include, ‘Chasing the Scream’, ‘Lost Connections’, and ‘Stolen Focus’. He has written for the world’s leading newspa ... Show More
2h 28m
Mar 2025
The State of Weight-Loss Drugs
$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big- ... Show More
30m 7s